National estimates of emergency department visits for angioedema and allergic reactions in the United States.

Abstract:

:Each year there are a substantial number of emergency department (ED) visits for angioedema and allergic reactions in the United States. Angioedema is commonly mistaken for an allergic reaction, possibly affecting the treatment rendered. We sought to determine the characteristics of U.S. ED visits for acute angioedema and to determine their differences from visits for allergic reactions. We used 2001-2009 data from the National Hospital Ambulatory Medical Care Survey. Using ED diagnoses (defined by the International Classification of Diseases, 9th Revision codes), we identified visits involving angioedema (ICD-9 277.6 and 995.1) or allergic reaction (ICD-9 995.6, 995.0, 995.4, 995.3, and 708). Accounting for the weighted sampling design, we determined the annual number of angioedema and allergic reaction cases, the characteristics of the affected patients, course of care, and patient outcomes. During 2001-2009 there were 1.05 billion ED visits, including 979,342 for angioedema and 8,814,601 for allergic reactions. These figures corresponded to 108,816 (95% CI, 82,246-132,386) annual visits for angioedema and 979,400 (CI, 874,562-1,084,238) annual visits for allergic reactions. Angioedema patients spent >3 hours in the ED and 11% were admitted to the hospital. Steroids and antihistamines were the most common treatments rendered for both angioedema and allergic reaction patients. There are >100,000 annual visits for angioedema in the United States, with key differences and similarities between allergic reaction and angioedema cases. These findings underscore the large number of angioedema cases presenting to U.S. EDs and the opportunities for novel angioedema therapy use in this setting.

journal_name

Allergy Asthma Proc

authors

Kelly M,Donnelly JP,McAnnally JR,Wang HE

doi

10.2500/aap.2013.34.3640

subject

Has Abstract

pub_date

2013-03-01 00:00:00

pages

150-4

issue

2

eissn

1088-5412

issn

1539-6304

journal_volume

34

pub_type

杂志文章
  • Comparison of serum-specific IgE (ImmunoCAP) and skin-prick test results for 53 inhalant allergens in patients with chronic rhinitis.

    abstract::Prior studies comparing skin testing to serum-specific IgE testing for inhalant allergy focused on older technologies or small numbers of allergens. The purpose of this study was to compare ImmunoCAP (CAP) testing to skin prick testing (ST) for 53 inhalant allergens. Subjects > or =18 years old with chronic rhinitis a...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2009.30.3258

    authors: Calabria CW,Dietrich J,Hagan L

    更新日期:2009-07-01 00:00:00

  • A cost-effective approach to the diagnosis and treatment of the wheezing infant.

    abstract::Wheezing in infancy presents the clinician with at least two broad clinical problems. First is the task of distinguishing the common entities of bronchiolitis and asthma from rare, yet potentially life threatening illnesses that may present with wheezing. The second problem deals with the difficulties in distinguishin...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/108854197778984446

    authors: Mamlok R

    更新日期:1997-05-01 00:00:00

  • Heterogeneity of asthma and the risk of celiac disease in children.

    abstract:BACKGROUND:Although human leukocyte antigen (HLA)-DR and HLA-DQ genes and gluten play crucial roles in developing celiac disease (CD), most patients with these risk factors still do not develop CD, which indicates additional unrecognized risk factors. OBJECTIVE:To determine the association between asthma and the risk ...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2018.39.4100

    authors: Patel B,Wi CI,Hasassri ME,Divekar R,Absah I,Almallouhi E,Ryu E,King K,Juhn YJ

    更新日期:2018-01-01 00:00:00

  • Asthma burden in the United States: results of the 2009 Asthma Insight and Management survey.

    abstract::Updated guidelines and new treatments for asthma have become available since the last major survey of asthma management in the United States was completed ∼11 years ago. The Asthma Insight and Management (AIM) survey was conducted to assess the current status of asthma burden in the United States. A geographically str...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2011.32.3519

    authors: Meltzer EO,Blaiss MS,Nathan RA,Doherty DE,Murphy KR,Stoloff SW

    更新日期:2012-01-01 00:00:00

  • The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence.

    abstract::Perennial allergic rhinitis (PAR) often causes sleep disturbances and associated daytime somnolence, thus resulting in a poor quality of life. Various clinical interventions in patients suffering from the disorder seek to improve symptoms and quality of life. Additional studies are needed to establish whether the alle...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2008.29.3097

    authors: Santos CB,Hanks C,McCann J,Lehman EB,Pratt E,Craig TJ

    更新日期:2008-03-01 00:00:00

  • Latex hypersensitivity in a horse farmer.

    abstract::Latex immediate hypersensitivity has been documented in 28% to 67% of spina bifida patients, 2.6%-16.9% of health care workers and at least 1% of the general population. Additionally, it has been confirmed in food-sensitive individuals sensitive to cross-reacting foods such as chestnut, avocado, banana, and passion fr...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/108854196778645083

    authors: Randolph C,Fraser B

    更新日期:1996-03-01 00:00:00

  • Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs).

    abstract::Diagnosis of tuberculosis (TB) in children by the tuberculin skin test (TST) poses a diagnostic challenge for physicians due to its low specificity and cross-reactivity with nontuberculous mycobacteria and bacille Calmette-Guerin (BCG). Although interferon-gamma release assays (IGRAs) have been shown as novel TST alte...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2012.33.3574

    authors: Riazi S,Zeligs B,Yeager H,Peters SM,Benavides GA,Di Mita O,Bellanti JA

    更新日期:2012-05-01 00:00:00

  • New developments in inhaled corticosteroids.

    abstract::Inhaled corticosteroids (ICSs) are the foundation of pharmacotherapy in persistent asthma because they control airway inflammation. The anti-inflammatory effect of ICSs is primarily topical, at their site of deposition in the airways. Consequently, deposition characteristics of the ICS and its formulation and inhalati...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2006.27.2929

    authors: Colice GL

    更新日期:2006-09-01 00:00:00

  • Chronic urticaria as a presenting sign of hairy cell leukemia.

    abstract::Chronic urticaria is a common clinical disorder that is idiopathic in over 75% of cases. Less commonly, urticaria may be the presenting manifestation of an allergic or infectious disease, endocrinopathy, inherited syndrome, or autoimmune disorder. Rarely, urticaria may be a sign of underlying malignancy, including leu...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/108854199778681530

    authors: Clore LS Jr,Stafford CT

    更新日期:1999-01-01 00:00:00

  • A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score.

    abstract::Rhinitis symptom complex consists of rhinorrhea, congestion, itchy mucosa, itchy eyes, and sneezing. Available medications vary in their benefit for each of these symptoms. It was the purpose of this article to compare symptom reduction with three different classes of medications. Montelukast, azelastine, and budesoni...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2010.31.3308

    authors: Sardana N,Santos C,Lehman E,Craig T

    更新日期:2010-01-01 00:00:00

  • Serum levels of specific immunoglobulin E to Dermatophagoides pteronyssinus allergen components in patients with allergic rhinitis or/and asthma.

    abstract::Background: House-dust mites (HDM) allergen is one of the most important allergens in southern China; however, studies on the Dermatophagoides pteronyssinus components are relatively lacking. Objective: This study analyzed the molecular components of D. pteronyssinus in patients with allergic asthma (AS) and/or allerg...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2021.42.200105

    authors: Zou X,Hu H,Huang Z,Liao C,Huang L,Luo W,Jiang M,Sun B

    更新日期:2021-01-01 00:00:00

  • Current Allergic Rhinitis Experiences Survey (CARES): Consumers' awareness, attitudes and practices.

    abstract::Allergic rhinitis (AR) affects ~60 million people in the United States. This study evaluates awareness, attitudes, and behaviors of AR sufferers on the management of their condition. This U.S.-based survey evaluated 1600 adult AR sufferers to assess their perceptions of AR diagnosis, treatment preferences, and interac...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2014.35.3766

    authors: Fromer LM,Blaiss MS,Jacob-Nara JA,Long RM,Mannion KM,Lauersen LA

    更新日期:2014-07-01 00:00:00

  • An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.

    abstract::Intranasal steroids have been shown to affect ocular symptoms of allergic rhinitis (AR). The results of the published literature, however, are not uniform across all products. This study was designed to evaluate whether the effects of fluticasone furoate nasal spray (FFNS) are consistent across different allergy seaso...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2010.31.3397

    authors: Maspero JF,Walters RD,Wu W,Philpot EE,Naclerio RM,Fokkens WJ

    更新日期:2010-11-01 00:00:00

  • Multiple-dose proportionality study of flunisolide hydrofluoroalkane.

    abstract::The hydrofluoroalkane (HFA) formulation of the inhaled corticosteroid flunisolide is a modification of the original chlorofluorocarbon formulation. HFA flunisolide substitutes an HFA for a chlorofluorocarbon propellant and uses a built-in spacer in its pressurized metered-dose inhaler. An open-label, randomized, three...

    journal_title:Allergy and asthma proceedings

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Nolting A,Abramowitz W

    更新日期:2002-09-01 00:00:00

  • Usefulness of offline fractional exhaled nitric oxide measurements in the elderly asthmatic patients.

    abstract::Fractional exhaled nitric oxide (FeNO) measurement is an important noninvasive tool for evaluating eosinophilic inflammation of the airways. However, measurement of online FeNO in elderly people may not be possible if they are unable to perform the expiratory maneuver. The offline FeNO test is an alternative method th...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2013.34.3692

    authors: Hsu JY,Huang WC,Huang PL,Cheng YW,Chou MC

    更新日期:2013-09-01 00:00:00

  • Properties of the ideal corticosteroid therapy.

    abstract::Currently, inhaled corticosteroids (ICSs) are the most effective long-term control therapy for persistent asthma. However, patients show a variable response to ICSs and some exhibit glucocorticoid resistance. At recommended doses, there is little evidence to suggest that ICSs can either prevent or reverse the chronic ...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:

    authors: Zitt MJ

    更新日期:2005-05-01 00:00:00

  • Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: an updated review.

    abstract::Flunisolide hydrofluoroalkane (HFA) with integrated spacer is the most recent reformulated inhaled corticosteroid (ICS) for asthma available in the United States. It is the only product that combines a corticosteroid extrafine aerosol with a built-in spacer. The potential clinical benefit of the flunisolide HFA formul...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2015.36.3835

    authors: Berger WE,Tashkin DP

    更新日期:2015-03-01 00:00:00

  • A 64-year-old man with chronic obstructive pulmonary disease and an atypical rash.

    abstract::A 64-year-old male patient with a 15-year history of chronic obstructive pulmonary disease presented with an atypical rash that was refractory to standard therapy. Pulmonary function tests confirmed an obstructive lung disease. Basic laboratory workup revealed conflicting information, leading to a diagnostic challenge...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2011.32.3430

    authors: Craig ET,Banta E,Craig TJ

    更新日期:2011-07-01 00:00:00

  • Allergic bronchopulmonary aspergillosis in an HIV-infected individual.

    abstract::Aspergilloma and invasive aspergillosis have been reported in HIV-infected individuals. Allergic Bronchopulmonary Aspergillosis (ABPA) is a lung disease marked by a hypersensitivity response to inhaled aspergillus species, most commonly Aspergillus fumigatus (Af). This manifestation of Af has previously not been repor...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/108854100778249051

    authors: Jain M

    更新日期:2000-11-01 00:00:00

  • Chapter 27: Approach to primary immunodeficiency.

    abstract::Primary immunodeficiency diseases (PID) are inherited defects of the innate or adaptive arms of the immune system that lead to an increase in the incidence, frequency, or severity of infections. There may be defects in the adaptive arm of the immune system that include combined immunodeficiency and antibody deficienc...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2012.33.3560

    authors: Uzzaman A,Fuleihan RL

    更新日期:2012-05-01 00:00:00

  • Delayed food-dependent, exercise-induced anaphylaxis.

    abstract::Food-dependent, exercise-induced anaphylaxis (FDEIA) is a clinically distinct form of anaphylaxis in which symptoms occur only when the patient exercises within a few hours of eating the food. Its precise mechanism remains unclear and has been reported to have a wide spectrum of presentations. The objective of this re...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2007.28.2951

    authors: Oyefara BI,Bahna SL

    更新日期:2007-01-01 00:00:00

  • The relationship between insect sting allergy treatment and patient anxiety and depression.

    abstract::Quality of life is affected by history of bee sting allergy. In addition, worry about being stung and also the need to use self-injection of medicine can create or increase anxiety, which can further compromise a patient's ability to enjoy the outdoors and participate in activities. We sought to determine the depressi...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2014.35.3751

    authors: Findeis S,Craig T

    更新日期:2014-05-01 00:00:00

  • Management of asthma in adults: do the patients get what they need--and want?

    abstract::Suboptimal asthma control may be caused by a combination of factors, such as nonadherence to guidelines, lack of compliance, and poor asthma education. The aim was to assess patients' knowledge of asthma and different management strategies, including patients' attitudes toward involvement in treatment decisions. The p...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2007.28.3001

    authors: Backer V,Ulrik CS,Harving H,Lange P,Søes-Petersen U,Plaschke PP

    更新日期:2007-05-01 00:00:00

  • Hereditary and acquired angioedema.

    abstract::Hereditary angioedema (HAE) is an autosomal dominant disorder defined by a deficiency of functional C1 esterase inhibitor (C1-INH). Acquired angioedema is due to either consumption (type 1) or inactivation (type 2) of CI-INH. Both HAE and acquired angioedema can be life-threatening. Of the three types of HAE, type 1 i...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,评审

    doi:10.2500/aap.2019.40.4267

    authors: Patel G,Pongracic JA

    更新日期:2019-11-01 00:00:00

  • Rhinorrhea not responding to nasal corticosteroids.

    abstract::A woman with multiple illnesses including allergic rhinitis presented for a follow-up visit at our clinic with constant rhinorrhea for 2 weeks despite regular use of nasal corticosteroids. Two weeks earlier, after alcohol drinking and doubling some of her medications for missed doses, she fell on her face. The Emergen...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2007.28.3061

    authors: Patel PN,Oyefara B,Aarstad R,Bahna SL

    更新日期:2007-11-01 00:00:00

  • Pharmaceutical care for asthma patients: a community pharmacy-based pilot project.

    abstract::Asthma is a clinical problem with social, psychological, and economic burdens. To improve patient disease management and quality of life (QOL), different education programs have been developed. The purpose of this study is to adapt and implement a community-based educational program for patients with asthma. A prospec...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,随机对照试验

    doi:10.2500/aap2008.29.3083

    authors: Petkova VB

    更新日期:2008-01-01 00:00:00

  • When asthma and rhinitis coexist, could rhinitis reduce asthma control in children?

    abstract:Background:Bronchial asthma and rhinitis are among the most common diseases in children and frequently coexist in the patient. The primary aim of anti-asthmatic therapy is disease control. Several questionnaires can be used in pediatrics to assess asthma control and the Children Asthma Control Test (C-ACT) is one of th...

    journal_title:Allergy and asthma proceedings

    pub_type: 信件

    doi:10.2500/aap.2019.40.4219

    authors: De Vittori V,Pacilio A,Indinnimeo L,Marazzato M,De Castro G,Brindisi G,Schiavi L,Tosca M,Duse M,Zicari AM

    更新日期:2019-05-01 00:00:00

  • Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy.

    abstract::Anti-IgE therapy with omalizumab, a recombinant humanized monoclonal antibody, has anti-inflammatory effects in allergic asthma and rhinitis. Although omalizumab has been exceptionally safe, reactions after its administration have been reported. The goal of this study was to assess two patients who experienced apparen...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2007.28.3003

    authors: Price KS,Hamilton RG

    更新日期:2007-05-01 00:00:00

  • The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007.

    abstract::Hereditary angioedema (HAE) is a rare inherited disorder of complement factor C1 inhibitor. HAE is frequently confused with angioedema (AE), and little is known about emergency department (ED) or hospital utilization by patients with attacks in the United States. We examined hospitalizations and ED utilization for HAE...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章

    doi:10.2500/aap.2010.31.3403

    authors: Zilberberg MD,Jacobsen T,Tillotson G

    更新日期:2010-11-01 00:00:00

  • Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to

    abstract::Dose-response of formoterol via pressurized metered-dose inhaler (pMDI) has not been determined in asthmatic pediatric patients aged 6 to <12 years. This study was designed to assess the bronchodilating dose-response of three formoterol pMDI doses in children with stable asthma aged 6 to <12 years receiving twice-dail...

    journal_title:Allergy and asthma proceedings

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.2500/aap.2014.35.3746

    authors: Berger WE,Gillen M,Eckerwall G,Uryniak T,Trudo FJ,Lampl KL

    更新日期:2014-03-01 00:00:00